BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baker MM, El-Kafrawy DS, Mahrous MS, Belal TS. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir. Ann Pharm Fr 2018;76:16-31. [PMID: 28842163 DOI: 10.1016/j.pharma.2017.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Aboras SI, Abdine HH, Ragab MAA, Korany MA. A Review on Analytical Strategies for the Assessment of Recently Approved Direct Acting Antiviral Drugs. Crit Rev Anal Chem 2021;:1-23. [PMID: 34138669 DOI: 10.1080/10408347.2021.1923456] [Reference Citation Analysis]
2 El-Shorbagy HI, Elsebaei F, Hammad SF, Elbrashy AM. Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: Application to average content and uniformity of dosage unit testing. Spectrochim Acta A Mol Biomol Spectrosc 2018;205:398-409. [PMID: 30044997 DOI: 10.1016/j.saa.2018.07.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
3 El-shorbagy HI, Elsebaei F, Hammad SF, El-brashy AM. Optimization and modeling of a green dual detected RP-HPLC method by UV and fluorescence detectors using two level full factorial design for simultaneous determination of sofosbuvir and ledipasvir: Application to average content and uniformity of dosage unit testing. Microchemical Journal 2019;147:374-92. [DOI: 10.1016/j.microc.2019.03.039] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
4 Atta NF, Galal A, Ahmed YM. New strategy for determination of anti-viral drugs based on highly conductive layered composite of MnO2/graphene/ionic liquid crystal/carbon nanotubes. Journal of Electroanalytical Chemistry 2019;838:107-18. [DOI: 10.1016/j.jelechem.2019.02.056] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
5 Keyvan K, Sohrabi MR, Motiee F. An intelligent method based on feed-forward artificial neural network and least square support vector machine for the simultaneous spectrophotometric estimation of anti hepatitis C virus drugs in pharmaceutical formulation and biological fluid. Spectrochim Acta A Mol Biomol Spectrosc 2021;263:120190. [PMID: 34332240 DOI: 10.1016/j.saa.2021.120190] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Abdel-aal FA, Rageh AH, Said MI, Saleh GA. ε-MnO2-modified graphite electrode as a novel electrochemical sensor for the ultrasensitive detection of the newly FDA approved Hepatitis C antiviral drug ledipasvir. Analytica Chimica Acta 2018;1038:29-40. [DOI: 10.1016/j.aca.2018.07.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
7 El-Shorbagy HI, Belal F. Innovative derivative/zero ratio spectrophotometric method for simultaneous determination of sofosbuvir and ledipasvir: Application to average content and uniformity of dosage units. Spectrochim Acta A Mol Biomol Spectrosc 2022;267:120623. [PMID: 34810100 DOI: 10.1016/j.saa.2021.120623] [Reference Citation Analysis]
8 Nasr JJ, Shalan S. Validated 1H and 19F nuclear magnetic resonance for the quantitative determination of the hepatitis C antiviral drugs sofosbuvir, ledipasvir, and daclatasvir in tablet dosage forms. Microchemical Journal 2020;152:104437. [DOI: 10.1016/j.microc.2019.104437] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hemdan A, Eissa MS. Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry. J Anal Sci Technol 2019;10. [DOI: 10.1186/s40543-019-0197-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Allahverdiyeva S, Keskin E, Pınar PT, Yunusoğlu O, Yardım Y, Şentürk Z. Electroanalytical investigation and determination of hepatitis C antiviral drug ledipasvir at a non-modified boron-doped diamond electrode. Diamond and Related Materials 2020;108:107962. [DOI: 10.1016/j.diamond.2020.107962] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
11 El-Gizawy SM, El-Shaboury SR, Atia NN, Abo-Zeid MN. New, simple and sensitive HPTLC method for simultaneous determination of anti-hepatitis C sofosbuvir and ledipasvir in rabbit plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2018;1092:432-9. [PMID: 29945107 DOI: 10.1016/j.jchromb.2018.06.033] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
12 Abdel-Tawab MA, Abd El-Moghny MG, El Nashar RM. Recent advances in the chromatographic determination of the most commonly used anti-hepatitis C drug sofosbuvir and its co-administered drugs in human plasma. Biomed Chromatogr 2022;36:e5238. [PMID: 34469609 DOI: 10.1002/bmc.5238] [Reference Citation Analysis]
13 Abdallah OM, Abdel-megied AM, Gouda AS. Pharmacokinetic evaluation of daclatasvir and ledipasvir in healthy volunteers using a validated highly sensitive spectrofluorimetric method. Luminescence 2018;33:1094-100. [DOI: 10.1002/bio.3514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Narenderan S, Babu B, Gokul T, Meyyanathan SN. A Novel Simultaneous Estimation of Sofosbuvir and Velpatasvir in Human Plasma by Liquid Chromatography Tandem-Mass Spectrometry after Protein Precipitation Method. CPA 2019;15:710-5. [DOI: 10.2174/1573412914666180910102353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
15 Baker MM, Hammad SF, Belal TS. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies. Drug Dev Ind Pharm 2019;45:1111-9. [PMID: 30929537 DOI: 10.1080/03639045.2019.1593444] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]